Diabetes Mellitus
Item
Presence of diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Wagner Stage
Item
Presence of a foot wound (chronic wounds; amputation wounds) Wagner stage 2-4
boolean
C0149697 (UMLS CUI [1])
Foot Wound: Length
Item
Existence of the foot wound for at least 4 weeks
boolean
C0149697 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Informed Consent
Item
Signed informed consent form
boolean
C0021430 (UMLS CUI [1])
Negative Pressure Wound Therapy
Item
Patient's eligibility of NPWT in the opinion of the treating physician
boolean
C1956078 (UMLS CUI [1])
Control Group
Item
Healthy Volunteers
boolean
C0009932 (UMLS CUI [1])
Age
Item
Age <18 years
boolean
C0001779 (UMLS CUI [1])
Compliance
Item
Non-Compliance
boolean
C1321605 (UMLS CUI [1])
Pregnancy
Item
Pregnancy
boolean
C0032961 (UMLS CUI [1])
Hypersensitivity to Study Drug
Item
Allergies regarding the release of substances from components of each treatment arm
boolean
C0020517 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Anemia
Item
Severe anemia, wich was not caused by an infection
boolean
C0002871 (UMLS CUI [1])
Study Participation Status
Item
Simultaneous participation of patients in another interventional study / previous participation in the same study
boolean
C2348568 (UMLS CUI [1])
Previous Negative Pressure Wound Therapy
Item
Use of NPWT systems to the study-related foot lesion within a period of 6 weeks prior to study inclusion
boolean
C0205156 (UMLS CUI [1,1])
C1956078 (UMLS CUI [1,2])
Necrotic tissue
Item
Presence of necrotic tissue with eschar, which can not be removed
boolean
C2321738 (UMLS CUI [1])
Osteitis or osteomyelitis
Item
Untreated osteitis or osteomyelitis
boolean
C0029400 (UMLS CUI [1])
C0029443 (UMLS CUI [2])
Fistula
Item
Not examined / unexplored fistula
boolean
C0016169 (UMLS CUI [1])
Malignancy
Item
Malignancy of the wound
boolean
C0006826 (UMLS CUI [1])
Site of Lesion
Item
Exposed: nerves, blood vessels, anastomotic site
boolean
C0449695 (UMLS CUI [1])
Bleeding Risk
Item
ambulant NPWT of patients receiving anticoagulants (especially heparinization or marcumar therapy) or with otherwise highly impaired clotting function, which have a risk of circulatory relevant bleeding
boolean
C3251812 (UMLS CUI [1])